Tenon Medical R&D Spending Growth & History (TNON)
Tenon Medical's r&d spending was $2.1M for fiscal 2025.
View full Tenon Medical company overviewTenon Medical annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.1M | −$454,000 | −17.44% |
| 2024 | 2024-12-31 | $2.6M | −$560,000 | −17.70% |
| 2023 | 2023-12-31 | $3.2M | $335,000 | +11.85% |
| 2022 | 2022-12-31 | $2.8M | $1.1M | +64.61% |
| 2021 | 2021-12-31 | $1.7M | — | — |
Tenon Medical quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $768,000 | $265,000 | +52.68% |
| Q1 2026 | 2026-03-31 | $662,000 | −$29,000 | −4.20% |
| Q4 2025 | 2025-12-31 | $527,000 | −$42,000 | −7.38% |
| Q3 2025 | 2025-09-30 | $428,000 | −$229,000 | −34.86% |
| Q2 2025 | 2025-06-30 | $503,000 | −$205,000 | −28.95% |
| Q1 2025 | 2025-03-31 | $691,000 | $22,000 | +3.29% |
| Q4 2024 | 2024-12-31 | $569,000 | −$122,000 | −17.66% |
| Q3 2024 | 2024-09-30 | $657,000 | −$80,000 | −10.85% |
| Q2 2024 | 2024-06-30 | $708,000 | −$193,000 | −21.42% |
| Q1 2024 | 2024-03-31 | $669,000 | −$165,000 | −19.78% |
| Q4 2023 | 2023-12-31 | $691,000 | −$121,000 | −14.90% |
| Q3 2023 | 2023-09-30 | $737,000 | −$60,000 | −7.53% |
| Q2 2023 | 2023-06-30 | $901,000 | $244,000 | +37.14% |
| Q1 2023 | 2023-03-31 | $834,000 | $272,000 | +48.40% |
| Q4 2022 | 2022-12-31 | $812,000 | $19,000 | +2.40% |
| Q3 2022 | 2022-09-30 | $797,000 | $196,000 | +32.61% |
| Q2 2022 | 2022-06-30 | $657,000 | $420,000 | +177.22% |
| Q1 2022 | 2022-03-31 | $562,000 | $475,000 | +545.98% |
| Q4 2021 | 2021-12-31 | $793,000 | — | — |
| Q3 2021 | 2021-09-30 | $601,000 | — | — |
| Q2 2021 | 2021-06-30 | $237,000 | — | — |
| Q1 2021 | 2021-03-31 | $87,000 | — | — |
Tenon Medical r&d spending trends
Between the periods ended 2021-12-31 and 2025-12-31, Tenon Medical's r&d spending increased from $1.7M to $2.1M, a change of $431,000. The latest reported quarter, Q2 2026, shows $768,000.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tenon Medical source filings ↗